A physician must determine the cancer’s stage before deciding on treatment, says Cathy Eng, professor and director, Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center. Treatment options are vastly different in the early stage and in the metastatic setting.
Deciding on treatments is a bit like a game of chess, says John L. Marshall, chief, Division of Hematology/Oncology, Georgetown University Hospital, associate director, Clinical Research, Lombardi Comprehensive Cancer Center.
“[W]e’re going to play a smart chess game that balances the toxicity and side effects versus the control of the cancer,” Marshall says.
The Sport of Cancer: How One Survivor Linked Ironman Training and Colorectal Cancer
February 16th 2023Teri Griege completed an Ironman triathlon in 2009, and less than a month later received a stage 4 colorectal cancer diagnosis. In this episode of Cancer Horizons, she shared her story.
Listen
‘Let’s Go After This Thing and Fight’ Urges a Long-Time Survivor of Early-Onset CRC
January 27th 2022In this episode of the “Cancer Horizons” podcast, a woman living with colorectal cancer who was diagnosed 14 years ago at age 29 discusses what it was like to be the youngest person in the treatment room, and how she found another community of young survivors.
Listen